Duraisamy Balaguru, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Vessel Anomalies | 5 | 2020 | 314 | 1.670 |
Why?
|
| Aneurysm, Infected | 1 | 2017 | 85 | 0.570 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2010 | 478 | 0.510 |
Why?
|
| Cyanosis | 1 | 2015 | 83 | 0.500 |
Why?
|
| Coronary Sinus | 1 | 2015 | 87 | 0.480 |
Why?
|
| Community-Acquired Infections | 1 | 2017 | 465 | 0.450 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2015 | 573 | 0.450 |
Why?
|
| Aortic Aneurysm | 1 | 2017 | 644 | 0.430 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2015 | 488 | 0.410 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 687 | 0.370 |
Why?
|
| Renal Circulation | 1 | 2011 | 334 | 0.370 |
Why?
|
| Hypolipidemic Agents | 1 | 2015 | 606 | 0.360 |
Why?
|
| Alloys | 1 | 2010 | 122 | 0.350 |
Why?
|
| Abdominal Wall | 1 | 2011 | 157 | 0.350 |
Why?
|
| Septal Occluder Device | 1 | 2010 | 128 | 0.330 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2011 | 263 | 0.330 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 1400 | 0.320 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 1125 | 0.310 |
Why?
|
| Hepatitis C | 1 | 2018 | 1591 | 0.300 |
Why?
|
| Dyslipidemias | 1 | 2015 | 851 | 0.300 |
Why?
|
| Strabismus | 1 | 2011 | 283 | 0.300 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 1416 | 0.300 |
Why?
|
| Chylothorax | 2 | 2020 | 84 | 0.290 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2003 | 1133 | 0.290 |
Why?
|
| Foramen Ovale, Patent | 1 | 2010 | 223 | 0.290 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 1911 | 0.290 |
Why?
|
| Vascular Fistula | 1 | 2006 | 50 | 0.270 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2011 | 717 | 0.270 |
Why?
|
| Antiviral Agents | 1 | 2018 | 2984 | 0.260 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 814 | 0.250 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 1869 | 0.240 |
Why?
|
| Mucopolysaccharidosis IV | 1 | 2021 | 7 | 0.210 |
Why?
|
| Pulsatile Flow | 1 | 2003 | 332 | 0.200 |
Why?
|
| Chondroitinsulfatases | 1 | 2021 | 16 | 0.200 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2021 | 78 | 0.190 |
Why?
|
| Noonan Syndrome | 1 | 2020 | 122 | 0.180 |
Why?
|
| Postoperative Complications | 4 | 2020 | 15281 | 0.180 |
Why?
|
| Radiology, Interventional | 1 | 2003 | 460 | 0.170 |
Why?
|
| Point-of-Care Systems | 2 | 2020 | 1177 | 0.170 |
Why?
|
| Embolization, Therapeutic | 2 | 2006 | 1392 | 0.170 |
Why?
|
| Femoral Artery | 1 | 2003 | 845 | 0.160 |
Why?
|
| Atherosclerosis | 1 | 2015 | 3445 | 0.160 |
Why?
|
| Lymphography | 2 | 2020 | 201 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7270 | 0.150 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 1997 | 158 | 0.150 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2003 | 1263 | 0.140 |
Why?
|
| Aortography | 1 | 2017 | 437 | 0.130 |
Why?
|
| Myocarditis | 1 | 2023 | 768 | 0.130 |
Why?
|
| Infant | 10 | 2021 | 35122 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2003 | 2162 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 1 | 2000 | 957 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2000 | 1195 | 0.110 |
Why?
|
| Neurophysins | 1 | 2012 | 14 | 0.110 |
Why?
|
| Norwood Procedures | 1 | 2014 | 182 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2017 | 1186 | 0.100 |
Why?
|
| Myocardial Contraction | 1 | 1997 | 1579 | 0.100 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 1365 | 0.100 |
Why?
|
| Hormone Antagonists | 1 | 2012 | 108 | 0.100 |
Why?
|
| Equipment Safety | 2 | 2010 | 263 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2015 | 1851 | 0.090 |
Why?
|
| Vasopressins | 1 | 2012 | 370 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 1 | 2018 | 1029 | 0.090 |
Why?
|
| Benzazepines | 1 | 2012 | 326 | 0.090 |
Why?
|
| Foreign-Body Reaction | 1 | 2010 | 158 | 0.090 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 2150 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15067 | 0.090 |
Why?
|
| Child | 8 | 2023 | 77637 | 0.080 |
Why?
|
| Infant, Newborn | 6 | 2020 | 25609 | 0.080 |
Why?
|
| Hyponatremia | 1 | 2012 | 297 | 0.080 |
Why?
|
| Humans | 23 | 2023 | 743811 | 0.080 |
Why?
|
| Enterovirus Infections | 1 | 2008 | 72 | 0.080 |
Why?
|
| Child, Preschool | 7 | 2021 | 40964 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20121 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2014 | 1485 | 0.080 |
Why?
|
| Protein Precursors | 1 | 2012 | 1154 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 864 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 1391 | 0.070 |
Why?
|
| South Carolina | 2 | 2003 | 99 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2002 | 3537 | 0.070 |
Why?
|
| Adolescent | 8 | 2023 | 85729 | 0.070 |
Why?
|
| Mitral Valve Stenosis | 1 | 2007 | 376 | 0.060 |
Why?
|
| Male | 12 | 2021 | 349776 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 1738 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2010 | 2103 | 0.060 |
Why?
|
| Infant Welfare | 1 | 2003 | 81 | 0.060 |
Why?
|
| Heart Failure | 2 | 2012 | 10896 | 0.050 |
Why?
|
| Diuretics | 2 | 2008 | 591 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2011 | 1775 | 0.050 |
Why?
|
| Cardiotonic Agents | 2 | 2008 | 535 | 0.050 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2003 | 194 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 4584 | 0.050 |
Why?
|
| Prevalence | 1 | 2018 | 15211 | 0.050 |
Why?
|
| Vascular Patency | 1 | 2003 | 887 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3503 | 0.040 |
Why?
|
| Calcinosis | 1 | 2008 | 1495 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 7172 | 0.040 |
Why?
|
| Radiography, Interventional | 1 | 2006 | 1095 | 0.040 |
Why?
|
| Child Welfare | 1 | 2003 | 523 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2003 | 793 | 0.040 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2000 | 303 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 1997 | 142 | 0.040 |
Why?
|
| Echocardiography | 1 | 2010 | 5096 | 0.040 |
Why?
|
| Siblings | 1 | 2021 | 853 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 1911 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 2074 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 353 | 0.030 |
Why?
|
| Female | 10 | 2020 | 380020 | 0.030 |
Why?
|
| Ultrasonography | 3 | 2020 | 5986 | 0.030 |
Why?
|
| Transposition of Great Vessels | 1 | 2000 | 588 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2000 | 579 | 0.030 |
Why?
|
| Ventricular Function | 1 | 1997 | 415 | 0.030 |
Why?
|
| Adult | 3 | 2020 | 213889 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 974 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2003 | 1486 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1997 | 1297 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2023 | 2037 | 0.030 |
Why?
|
| Trachea | 1 | 2020 | 1076 | 0.030 |
Why?
|
| Sepsis | 1 | 2008 | 2593 | 0.030 |
Why?
|
| Length of Stay | 2 | 2008 | 6311 | 0.030 |
Why?
|
| Lymphedema | 1 | 2020 | 534 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2012 | 63042 | 0.030 |
Why?
|
| Sodium | 1 | 1997 | 1622 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 1997 | 2725 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 3175 | 0.020 |
Why?
|
| Rabbits | 1 | 1997 | 4894 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 39001 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 1903 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12243 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2000 | 4197 | 0.020 |
Why?
|
| Acute Disease | 1 | 2000 | 7150 | 0.020 |
Why?
|
| Indoles | 1 | 1997 | 1841 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 11708 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2000 | 3106 | 0.020 |
Why?
|
| Child Development | 1 | 2000 | 2212 | 0.020 |
Why?
|
| Cytokines | 1 | 2023 | 7324 | 0.020 |
Why?
|
| Rheumatic Heart Disease | 1 | 2007 | 177 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 2008 | 621 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 1997 | 3817 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2000 | 9139 | 0.020 |
Why?
|
| Pediatrics | 1 | 2000 | 3474 | 0.020 |
Why?
|
| Calcium | 1 | 1997 | 5755 | 0.020 |
Why?
|
| Disease Progression | 1 | 2000 | 13273 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2008 | 582 | 0.010 |
Why?
|
| Age Factors | 1 | 2000 | 18355 | 0.010 |
Why?
|
| Catheterization | 1 | 2007 | 1469 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1997 | 19232 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 40038 | 0.010 |
Why?
|
| Aged | 2 | 2010 | 163178 | 0.010 |
Why?
|
| Middle Aged | 2 | 2010 | 213241 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2008 | 2568 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 7010 | 0.010 |
Why?
|
| Device Removal | 1 | 2002 | 655 | 0.010 |
Why?
|
| Young Adult | 1 | 2023 | 56392 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 53250 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 5002 | 0.010 |
Why?
|
| Equipment Design | 1 | 2002 | 3574 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15526 | 0.010 |
Why?
|
| Patient Selection | 1 | 2002 | 4210 | 0.010 |
Why?
|
| Animals | 1 | 1997 | 168660 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 57744 | 0.000 |
Why?
|